15/11/2007 (Agence Europe) - Adopting by show of hands under the consultation procedure, in Strasbourg on Wednesday 14 November, a report by Jean-Marie Cavada (ALDE, France) on the Council's decision defining l-benzylpiperazine (BZP) as a new synthetic mood-altering drug (narcotic) that must be monitored and outlawed, the European Parliament approved the Commission's text. Although believing that BZP should be monitored as a matter of precaution, the MEPs nevertheless agreed with Cavada on...